	Nivolumab in gastric cancer with liver metastasis complicated by immune-mediated hepatitis: a case report and FAERS database analysis. Front Immunol Zhang YL, Zhao JL, Qu KJ, Jiao ZL, Chen YR, Zhou J, Li JL, Li JW. PMID: 41200202 [PubMed - indexed for MEDLINE]
	Identification of immunogenic cell death signature genes in hepatocellular carcinoma: from single-cell transcriptomics to in vitro mechanistic validation and comprehensive prognostic modeling with hundreds of machine learning algorithms. Front Immunol Liu H, Sun Z, Wang X, Zhou B, Cha L. PMID: 41200185 [PubMed - indexed for MEDLINE]
	Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study. Front Immunol Zhao Z, Xiao Y, Su CG, Zhao H, Li J, Liu J. PMID: 41200181 [PubMed - indexed for MEDLINE]
	Radiological characteristics for guiding intra-arterial therapy in intermediate-stage hepatocellular carcinoma. BMC Med An C, Zheng G, Zhou J, Wei R, Wu P, Zuo M. PMID: 41199230 [PubMed - indexed for MEDLINE]
	Study on the Mechanism of CCN2 Promoting Sorafenib Resistance in HCC and Its Combined Intervention Strategy. Front Biosci (Landmark Ed) Cui L, Liu J, Lv Y, Chen B, Liu K, Bu Y. PMID: 41198556 [PubMed - indexed for MEDLINE]
	Artificial Intelligence in the Evolution of Interventional Therapy for Liver Cancer: Navigating the Tumor Microenvironment. Front Biosci (Landmark Ed) Xiu Z, Zeng W, Guo J, Tu G, Chen X, Sheng J, Chen H. PMID: 41198535 [PubMed - indexed for MEDLINE]
	Benefit and prognosis prediction of radiation therapy in colorectal cancer liver metastases: a retrospective, population-based, propensity score-matched study. BMJ Open Wei T, Pan Z, Feng X, Long Y. PMID: 41198210 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study. PLoS One Ishii M, Itano O, Iwamoto H, Takami Y, Okada N, Inoue T, Itano S. PMID: 41196875 [PubMed - indexed for MEDLINE]
	Predicting Outcomes in Hepatocellular Carcinoma Surgery: ALBI is the Better Tool. An Observational Cohort Study. Chirurgia (Bucur) Zaharia R, Morarasu S, Ivanov AA, Dimofte GM, Lunca S. PMID: 41196082 [PubMed - indexed for MEDLINE]
	Augmented Reality Integration for Surgical Enhancement in Hepatic Surgery - Review of the Current Literature. Chirurgia (Bucur) Andra, Ilie, Ilie-Ene A, E, BinÃ inÃ An V, Dindelegan G. PMID: 41196075 [PubMed - indexed for MEDLINE]
	Solid Pseudopapillary Neoplasm of the Diaphragm: A Case Report. Isr Med Assoc J Gerszman E, Sonkin V, Sabo E, Radzishevsky N, Haddad R, Mahamid A. PMID: 41196001 [PubMed - indexed for MEDLINE]
	Development of a machine learning model to predict overall survival for large hepatocellular carcinoma at BCLC stage A or B after curative hepatectomy. Front Immunol Yang TX, Su JY, Li MJ, Shen S, Wang Y, Wei HN, Huang MJ, Qin QM, Ran YY, Huang YT, Huang JY, Xiang BD, Zhang J, Gong WF. PMID: 41194935 [PubMed - indexed for MEDLINE]
	Preoperative plasma ceramide profiling coupled with machine learning accurately predicts recurrence of hepatocellular carcinoma after resection. Lipids Health Dis Lei Y, Xie C, Mo X, Zhuang B, Li Q, Liu C, Liao L, Wang B, Zeng M, Tang S, Liu H, Xiao Y, Li S, Cai D, Li C, Zhou J, Li J, Li Y, Wang K. PMID: 41194075 [PubMed - indexed for MEDLINE]
	ACR Appropriateness CriteriaÂ® Staging and Follow-Up of Primary Liver Cancer. J Am Coll Radiol Expert Panel on Gastrointestinal Imaging, Smith EN, Bashir MR, Fung A, Cash BD, Dixon M, Hecht EM, McGuire BM, Pillai AA, Russo GK, Shroff RT, Thakrar KH, Vij A, Wahab SA, Wong TZ, Zaheer A, Fowler KJ. PMID: 41193053 [PubMed - indexed for MEDLINE]
	Harnessing big data for precision medicine: radiomics based application of nanomaterials in MRI enhancement and multimodal therapy of hepatocellular carcinoma. Front Immunol Shen H, Ran D, Zhu J, Tao A, Zheng K, Zhu Q, Wang H. PMID: 41190074 [PubMed - indexed for MEDLINE]
	One-stage versus two-stage surgery for initially unresectable colorectal cancer liver metastases: post hoc analysis of the CAIRO5 trial. BJS Open Bond MJG, Bolhuis K, van Amerongen MJ, Chapelle T, van Dam RM, Engelbrecht MRW, Gerhards MF, Grünhagen DJ, van Gulik T, Hermans JJ, de Jong KP, Kazemier G, Klaase JM, Kok NFM, Leclercq WKG, Liem MSL, van Lienden KP, Molenaar IQ, Patijn GA, Rijken AM, Ruers TM, Verhoef C, de Wilt JHW, May AM, Punt CJA, Swijnenburg RJ. PMID: 41189486 [PubMed - indexed for MEDLINE]
	Risk factors for hepatocellular carcinoma rupture: multicentre retrospective study. BJS Open Xia F, Liu Y, Huang H, Liu X, Yan J, Qiu Z, Zhang Q, Wu Z, Huang Z, Wei R, Lin L, Liu L, Han S, Yuan Y, Yin H, Xia G, Wan Y, Xiao S, Zhou G, Xia X, Sun H, Wang S, Zheng J, Gao H, Zheng J, Ren L, Mo A, Ye L, Ruan S, Chen X, Cheng Q, Zhang B, Zhu P. PMID: 41189483 [PubMed - indexed for MEDLINE]
	Association between NAFLD and liver cancer: A two-sample Mendelian randomization study. Medicine (Baltimore) Chen F, Zhang X. PMID: 41189220 [PubMed - indexed for MEDLINE]
	Hypoxia-mediated m(6)A modulation in hepatocellular carcinoma: a comprehensive review. J Transl Med Jiang HT, Qian SY, Di PR, Jin CC, Pu QH. PMID: 41188866 [PubMed - indexed for MEDLINE]
	Impact of all-oral direct-acting antivirals on hepatocellular carcinoma in Vietnamese patients with chronic HCV genotype 1. J Infect Dev Ctries Vo TD, Bui VT. PMID: 41187193 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 73484

Page 1 of 3675



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy